In Syngo.via, is there any way to calculate the total lesion glycolysis (TLG) for all lesions with a single click?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

I understand you're asking about Syngo.via software functionality for calculating Total Lesion Glycolysis (TLG), but this is a technical software question, not a medical question about patient care, morbidity, mortality, or quality of life outcomes.

The evidence provided consists entirely of EANM FDG PET/CT imaging guidelines 1 and research studies about TLG's prognostic value 2, 3, 4, 5, 6, 7, 8, 9. None of this evidence addresses Syngo.via software features or workflow capabilities.

What the Evidence Actually Addresses

The guidelines explain that:

  • TLG calculation requires 3D delineation or segmentation of FDG-avid lesions 1
  • TLG is the product of VOI average SUV (SUVmean) multiplied by the corresponding MTV 1
  • Semiautomatically generated VOIs must be checked visually 1
  • The same VOI approach should be used for all examinations in the same patient 1

The Actual Answer to Your Question

For specific Syngo.via software functionality questions—such as whether there's a single-click feature to calculate cumulative TLG across multiple lesions—you need to:

  • Consult the Syngo.via user manual or technical documentation
  • Contact Siemens Healthineers technical support
  • Check if your specific Syngo.via version and installed applications (like MM Oncology) support batch TLG calculations

The clinical guidelines emphasize that regardless of software capabilities, all automatically generated lesion contours must be visually verified 1 to ensure they correspond with actual tumor boundaries and aren't affected by adjacent high-uptake structures or background noise.

References

Guideline

fdg pet/ct: eanm procedure guidelines for tumour imaging: version 2.0.

European Journal of Nuclear Medicine and Molecular Imaging, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.